{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:26:20Z","timestamp":1790137580447,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.bcp.2009.04.006","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T08:15:18Z","timestamp":1239783318000},"page":"224-230","source":"Crossref","is-referenced-by-count":12,"title":["Distinct interactions of 2\u2032- and 3\u2032-O-(N-methyl)anthraniloyl-isomers of ATP and GTP with the adenylyl cyclase toxin of Bacillus anthracis, edema factor"],"prefix":"10.1016","volume":"78","author":[{"given":"Srividya","family":"Suryanarayana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna L.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuequan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald H.","family":"Lushington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2009.04.006_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10409230290771537","article-title":"The structure and function of novel proteins of Bacillus anthracis and other spore-forming bacteria: development of novel prophylactic and therapeutic agents","volume":"37","author":"Jedrzejas","year":"2002","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.bcp.2009.04.006_bib2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/415396a","article-title":"Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin","volume":"415","author":"Drum","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2009.04.006_bib3","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1093\/emboj\/cdf681","article-title":"Physiological calcium concentrations regulate calmodulin binding and catalysis of adenylyl cyclase exotoxins","volume":"21","author":"Shen","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2009.04.006_bib4","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1073\/pnas.0306552101","article-title":"Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection","volume":"101","author":"Shen","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2009.04.006_bib5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1124\/mol.108.052340","article-title":"Molecular analysis of the interaction of anthrax adenylyl cyclase toxin, edema factor, with 2\u2032(3\u2032)-O-(N-(methyl)anthraniloyl)-substituted purine and pyrimidine nucleotides","volume":"75","author":"Taha","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2009.04.006_bib6","doi-asserted-by":"crossref","first-page":"19955","DOI":"10.1074\/jbc.M312560200","article-title":"Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides","volume":"279","author":"Gille","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2009.04.006_bib7","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1074\/jbc.M211292200","article-title":"2\u2032(3\u2032)-O-(N-methylanthraniloyl)-substituted GTP analogs: a novel class of potent competitive adenylyl cyclase inhibitors","volume":"278","author":"Gille","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2009.04.006_bib8","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1074\/jbc.M409076200","article-title":"Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2\u2032(3\u2032)-O-(N-methylanthraniloyl)-guanosine 5\u2032-triphosphate","volume":"280","author":"Mou","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2009.04.006_bib9","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1124\/mol.106.026427","article-title":"Broad specificity of mammalian adenylyl cyclase for interaction with 2\u2032,3\u2032-substituted purine- and pyrimidine-nucleotide inhibitors","volume":"70","author":"Mou","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2009.04.006_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0076-6879(97)78020-0","article-title":"Fluorescent nucleotide analogs: synthesis and applications","volume":"278","author":"Jameson","year":"1997","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.bcp.2009.04.006_bib11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0167-4838(83)90267-4","article-title":"New ribose-modified fluorescent analogs of adenine and guanine nucleotides available as substrates for various enzymes","volume":"742","author":"Hiratsuka","year":"1983","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2009.04.006_bib12","series-title":"SYBYL 7.2","year":"2006"},{"key":"10.1016\/j.bcp.2009.04.006_bib13","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","article-title":"Iterative partial equalization of orbital electronegativity: a rapid access to atomic charges","volume":"36","author":"Gasteiger","year":"1980","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bcp.2009.04.006_bib14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/jcc.540100804","article-title":"Validation of the general purpose Tripos 5.2 force field","volume":"10","author":"Clark","year":"1989","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bcp.2009.04.006_bib15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/jmbi.1996.0477","article-title":"A fast flexible docking method using an incremental construction algorithm","volume":"261","author":"Rarey","year":"1996","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bcp.2009.04.006_bib16","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1021\/jm00014a020","article-title":"Prediction of drug binding affinities by comparative binding energy analysis","volume":"38","author":"Ortiz","year":"1995","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2009.04.006_bib17","unstructured":"SIMCA-P, Umereics AB, July 2001."},{"key":"10.1016\/j.bcp.2009.04.006_bib18","series-title":"Principles of fluorescence spectroscopy","author":"Lakowicz","year":"1999"},{"key":"10.1016\/j.bcp.2009.04.006_bib19","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/mol.107.034413","article-title":"Molecular analysis of the interaction of Bordetella pertussis adenylyl cyclase with fluorescent nucleotides","volume":"72","author":"G\u00f6ttle","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2009.04.006_bib20","doi-asserted-by":"crossref","first-page":"13317","DOI":"10.1074\/jbc.M309535200","article-title":"Pro-nucleotide inhibitors of adenylyl cyclases in intact cells","volume":"279","author":"Laux","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2009.04.006_bib21","doi-asserted-by":"crossref","unstructured":"G\u00f6ttle M, Geduhn J, K\u00f6nig B, Gille A, H\u00f6cherl K, Seifert R. Characterization of mouse heart adenylyl cyclase. J Pharmacol Exp Ther; in press.","DOI":"10.1124\/jpet.109.150953"},{"key":"10.1016\/j.bcp.2009.04.006_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ab.2008.06.014","article-title":"A fluorimetric assay for real-time monitoring of adenylyl cyclase activity based on terbium norfloxacin","volume":"381","author":"Spangler","year":"2008","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bcp.2009.04.006_bib23","doi-asserted-by":"crossref","first-page":"11181","DOI":"10.1021\/bi00110a023","article-title":"Is there a rate-limiting step before GTP cleavage by H-ras p21?","volume":"30","author":"Rensland","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2009.04.006_bib24","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1021\/bi00080a016","article-title":"Mechanism of GTP hydrolysis by p21N-ras catalyzed by GAP: studies with a fluorescent GTP analogue","volume":"32","author":"Moore","year":"1993","journal-title":"Biochemistry"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209002640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209002640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T13:26:44Z","timestamp":1545312404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295209002640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0006295209002640"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2009.04.006","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}